Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
C2N Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
C2N Diagnostics

C2N Diagnostics

Series B

St. Louis-based C2N Diagnostics, LLC is a private firm specializing in protein diagnostic and therapeutic discovery.

HQ
St. Louis, MO, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Founded in St. Louis, C2N Diagnostics, LLC is a private company dedicated to advancing protein diagnostic and therapeutic discovery. Its core mission is to develop and commercialize novel diagnostics for Alzheimer’s disease and related neurodegenerative conditions to enhance treatment decisions and improve patient outcomes. The company offers state-of-the-art blood tests, including the PrecivityAD® and PrecivityAD2™ tests, which utilize proprietary liquid-chromatography-tandem mass spectrometry (LC-MS) methodologies to assess brain amyloid pathology.

C2N Diagnostics boasts a team of leading neurological scientists and researchers. Notable investors and affiliated individuals include prominent figures in the biotechnology and healthcare sectors. The company's key achievements include the successful development and commercialization of its Precivity™ tests, which have significantly impacted the early detection and management of Alzheimer’s disease. Through its innovative diagnostic solutions, C2N Diagnostics has made substantial contributions to the field of neurodegenerative disease research and patient care.

C2N Diagnostics - Similar Companies

Celestia Diagnostics logo

Celestia Diagnostics

Test Diagnostics logo

Test Diagnostics

Plasmonic Diagnostics logo

Plasmonic Diagnostics

Cx Precision Medicine logo

Cx Precision Medicine

cxprecisionm.com

Critical Diagnostics logo

Critical Diagnostics

Empowered Diagnostics logo

Empowered Diagnostics

Nowdiagnostics logo

Nowdiagnostics

nowdx.com

Banyan Biomarkers logo

Banyan Biomarkers

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Durin Technologies logo

Durin Technologies

Precipio logo

Precipio

precipiodx.com

Torpedo Diagnostics logo

Torpedo Diagnostics

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Eclipse Diagnostics logo

Eclipse Diagnostics

C2N Diagnostics - Quick Facts

Who are C2N Diagnostics' competitors?

Companies similar to C2N Diagnostics include Celestia Diagnostics, Test Diagnostics, Plasmonic Diagnostics and Cx Precision Medicine.

When was C2N Diagnostics founded?

C2N Diagnostics was founded in 2007.

Where is C2N Diagnostics' headquarters located?

C2N Diagnostics' headquarters is located in St. Louis, MO, US.

When was C2N Diagnostics' last funding round?

C2N Diagnostics' most recent funding round was for $15M (USD) in February 2023.

How much has C2N Diagnostics raised to-date?

As of Feb 16, 2023, C2N Diagnostics has raised a total of $37.2M (USD).

How many employees does C2N Diagnostics have?

C2N Diagnostics has 62 employees as of Feb 4, 2024.

C2N Diagnostics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified